White opaque substance within superficial elevated gastric neoplasia as visualized by magnification endoscopy with narrow-band imaging: a new optical sign for differentiating between adenoma and carcinoma - 23/08/11
Reprint requests: Kenshi Yao, MD, PhD, Department of Gastroenterology, Fukuoka University Chikushi Hospital, 1-1-1 Zokumyoin, Chikushino-city, Fukuoka 818-8502, Japan.Fukuoka, Japan
Abstract |
Background |
The microvascular pattern (MVP) as visualized by magnification endoscopy (ME) is a reliable marker for differentiating between benign and malignant gastric flat lesions. However, in cases of gastric neoplasia of 0-IIa type, it is sometimes impossible to visualize the MVP because a white opaque substance (WOS) obscures the subepithelial MVP.
Objective |
To investigate whether the morphology of the WOS could be a useful optical sign for discriminating between adenoma and carcinoma.
Setting |
Single tertiary referral center.
Materials |
Forty-six gastric neoplasias of only 0-IIa type (18 adenomas and 28 early carcinomas) were evaluated.
Intervention |
The prevalence and the morphology of the WOS as visualized by ME with narrow-band imaging (NBI) according to histologic type (adenoma vs carcinoma).
Main Outcome Measurements |
The WOS is more frequently present in adenomas than in carcinomas. With regard to the morphology of the WOS, 100% of the examples of WOS within adenomas demonstrated a regular distribution; in contrast, 83% of the examples of WOS within carcinomas showed an irregular distribution.
Results |
In cases in which a neoplasia of 0-IIa type showed either WOS with a regular distribution or a regular MVP, the sensitivity and specificity for discriminating adenoma from carcinoma were 94% and 96%, respectively.
Limitations |
The number of cases was limited. The WOS has not yet been characterized by chemical analysis.
Conclusion |
In cases in which the WOS is observed, rather than assessing the MVP, morphologic analysis of the WOS could be an alternative new optical sign for discriminating adenoma from carcinoma when using ME with NBI.
Le texte complet de cet article est disponible en PDF.Abbreviations : ESD, ME, MVP, NBI, WOS
Plan
| Presented at the 15th United European Gastroenterology Week, October 29, 2007, Paris, France (Gut 2007;56:A16). |
Vol 68 - N° 3
P. 574-580 - septembre 2008 Retour au numéro
Article précédent
- Endoscopic injection therapy for a bleeding exposed vessel in Crohn’s disease
- Takahiko Toyonaga, Mitsunobu Matsushita, Takayuki Matsumoto, Toshiro Fukui, Mika Omiya, Kazushige Uchida, Kazuichi Okazaki
- Clinical manifestations and management of buried bumper syndrome in patients with percutaneous endoscopic gastrostomy
- Tzong-Hsi Lee, Jaw-Town Lin
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?